CSF-concentrations of tau-protein, phospho-tau-protein (181) and amyloid-beta (1-42) in patients with stable and non-stable MCI

被引：0
|
作者：
Kaiser, E. [1 ]
Thomann, P. A. [1 ]
Seidl, U. [1 ]
Schroeder, J. [1 ]
机构：
[1] Univ Heidelberg, Dept Gen Psychiat, D-6900 Heidelberg, Germany
来源：
PHARMACOPSYCHIATRY | 2009年 / 42卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
A71
引用
收藏
页码：224 / 224
页数：1
相关论文
共 24 条
  • [1] Influence of delayed CSF storage on concentrations of phospho-tau protein (181), total tau protein and beta-amyloid (1-42)
    Kaiser, Elmar
    Schoenknecht, Peter
    Thomann, Philipp A.
    Hunt, Aoife
    Schroeder, Johannes
    [J]. NEUROSCIENCE LETTERS, 2007, 417 (02) : 193 - 195
  • [2] The concentrations of amyloid beta 1-42, total Tau and phospho-Tau181 in the CSF of patients with early dementia and MCI as measured with multiplexing technology
    Lewczuk, P
    Esselmann, H
    Maler, JM
    Bibl, M
    Kornhuber, J
    Wiltfang, J
    [J]. PHARMACOPSYCHIATRY, 2005, 38 (05) : 260 - 260
  • [3] CSF levels of β-amyloid 1-42, tau and phosphorylated tau protein in CADASIL
    Formichi, P.
    Parnetti, L.
    Radi, E.
    Cevenini, G.
    Dotti, M. T.
    Federico, A.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (11) : 1252 - 1255
  • [4] Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: Beta-amyloid(1-42), tau, phospho-tau-181 and total protein
    Marksteiner, Josef
    Hinterhuber, Hartmann
    Humpel, Christian
    [J]. DRUGS OF TODAY, 2007, 43 (06) : 423 - 431
  • [5] Beta-amlyoid 1-42 and tau-protein in cerebrospinal fluid of patients with Parkinson's disease dementia
    Mollenhauer, Brit
    Trenkwalder, Claudia
    von Ahsen, Nicolas
    Bibl, Mirko
    Steinacker, Petra
    Brechlin, Peter
    Schindehuette, Jan
    Poser, Sigrid
    Wiltfang, Jens
    Otto, Markus
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2006, 22 (03) : 200 - 208
  • [6] Tau Protein, beta-Amyloid 1-42 and Clusterin CSF Levels in Differential Diagnosis of Parkinsonian Syndrome with Dementia
    Vranova, Hana Prikrylova
    Henykova, Eva
    Kaiserova, Michaela
    Mensikova, Katerina
    Vastik, Miroslav
    Mares, Jan
    Hlustik, Petr
    Zapletalova, Jana
    Strnad, Miroslav
    Stejskal, David
    Kanovsk, Petr
    [J]. NEUROLOGY, 2013, 80
  • [7] Clinical use and analytical problems in amyloid-beta(1-42) and tau protein in cefalorachidic fluid as markers of Alzheimer's disease
    Kang, Ju-Hee
    Korecka, Magdalena
    Toledo, Jon B.
    Trojanowski, John Q.
    Shaw, Leslie M.
    [J]. BIOCHIMICA CLINICA, 2014, 38 (03) : 255 - 267
  • [8] Biochemical studies in Normal Pressure Hydrocephalus (NPH) patients: Change in CSF levels of amyloid precursor protein (APP), amyloid-beta (Aβ) peptide and phospho-tau
    Ray, Balmiki
    Reyes, Patricio F.
    Lahiri, Debomoy K.
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2011, 45 (04) : 539 - 547
  • [9] Folate and methylation status in relation to phosphorylated tau protein(181P) and β-amyloid(1-42) in cerebrospinal fluid
    Obeid, Rima
    Kasoha, Mariz
    Knapp, Jean-Pierre
    Kostopoulos, Panagiotis
    Becker, George
    Fassbender, Klaus
    Herrmann, Wolfgang
    [J]. CLINICAL CHEMISTRY, 2007, 53 (06) : 1129 - 1136
  • [10] Total tau protein, phosphorylated tau (181p) protein, β-amyloid1-42, and β-amyloid1-40 in cerebrospinal fluid of patients with dementia with Lewy bodies
    Mollenhauer, B
    Bibl, M
    Wiltfang, J
    Steinacker, P
    Ciesielczyk, B
    Neubert, K
    Trenkwalder, C
    Otto, M
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2006, 44 (02) : 192 - 195
123